GeM facilitated Rs 4 lakh crore transactions till January

India’s public procurement platform Government e Marketplace (GeM) has facilitated transactions of Rs 4 lakh crore till January.

As on 23rd January, 2025, GeM has clocked a gross merchandise value of Rs 4.09 Lakh Crore, which marks a growth of nearly 50% over the corresponding period last FY, a statement said.

Also ReadAmul reduces milk prices by Re 1 across India for one-litre packs – Here’s the reason why

The services segment accounted for Rs 2.54 lakh crore or 62% of the total GMV whereas the product segment accounted for Rs 1.55 lakh crore or 38% of the total.

On GeM, 19 new service categories have been introduced on the portal so far this financial year

Services segment has grown by almost 100% in comparison to the corresponding period in previous FY by facilitating procurement of specialised services like printing of debit cards, bulk email services, dark fibre leasing and operations management of data centres.

The ministries of coal, defence, petroleum and natural gas, power and steel were the top five procurers on GeM. With transacted order value of nearly Rs  1.63 lakh crore, the Ministry of Coal has emerged as the top procurer, with more than 320 high-value bids, worth approximately ₹42,000 Crore, placed for handling and transport services by Coal PSUs.

Also ReadAdani dismisses reports of Lanka power project cancellation

Since its operationalisation GeM portal has successfully facilitated over 2.59 Crore orders with a GMV of more than ₹11.64 Lakh Crore since inception.

The GeM has a network of more than 1.6 lakh government buyers and over 22.5 lakh sellers and service providers.

 » Read More

Related Articles

8th Pay Commission: Central govt to merge pay scales for Level 1-6 employees? Here’s what the new proposal says

8th Pay Commission: The National Council of Joint Consultative Machinery (JCM) Staff Side has submitted its recommendations for the Terms of Reference (ToR) for the 8th Central Pay Commission (CPC), advocating significant changes in pay structure, allowances and benefits for government employees. Among the key points of ToR is the proposal for merger of certain

Bharti Airtel Q3 Results: Profit surges 505.24% to Rs 14,781.20 crore, ARPU at Rs 245

Bharti Airtel on Thursday posted a profit of Rs 14,781.20 crore during the third quarter of FY25, reporting a growth of 505.24 per cent in comparison to Rs 2442.20 crore during the corresponding quarter of FY24. The telecom major recorded Q3 revenue from operations at Rs 45,129.30 crore, up 19.08 per cent as against Rs

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

8th Pay Commission: Central govt to merge pay scales for Level 1-6 employees? Here’s what the new proposal says

8th Pay Commission: The National Council of Joint Consultative Machinery (JCM) Staff Side has submitted its recommendations for the Terms of Reference (ToR) for the 8th Central Pay Commission (CPC), advocating significant changes in pay structure, allowances and benefits for government employees. Among the key points of ToR is the proposal for merger of certain

Bharti Airtel Q3 Results: Profit surges 505.24% to Rs 14,781.20 crore, ARPU at Rs 245

Bharti Airtel on Thursday posted a profit of Rs 14,781.20 crore during the third quarter of FY25, reporting a growth of 505.24 per cent in comparison to Rs 2442.20 crore during the corresponding quarter of FY24. The telecom major recorded Q3 revenue from operations at Rs 45,129.30 crore, up 19.08 per cent as against Rs

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

Two banking stocks to watch ahead of the RBI Policy

By Kiran Jani Bank Nifty reached its all-time high of 54,467 in September 2024. Following this peak, the index experienced a correction, dipping to 47,844 in January 2025—a decline of 7.29%. Despite this pullback, Kotak Bank and ICICI Bank showed relative resilience, delivering returns of 1.61% and -4.20%, respectively, during the same period. Source: Investing.com

New Tax Regime: These deductions, exemptions still available for you

The Indian government introduced a new tax regime in 2020, offering lower tax rates while removing several exemptions and deductions available under the old system. Initially optional, this regime became the default in 2023, requiring taxpayers to opt out if they wished to continue under the old structure. Despite the removal of many benefits, certain